KAHR Medical
PrivateLast Round
VC Round
Jan 8, 2026
Est. Valuation
$16M
Total Funding Raised
$47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KAHR Medical is a biotechnology company that develops dual-targeting fusion protein therapeutics designed to activate both the innate and adaptive immune systems to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KAHR Medical Comparables
Compare KAHR Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QLSF Biotherapeutics | 76% | |
| ALX Oncology | 76% | |
| Gilead Sciences | 73% | |
KAHR Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 8, 2026 | ||||
| Series B | Oct 14, 2025 | ||||
| Series D Extension | Nov 17, 2022 | ||||
| VC Round | Jun 16, 2021 | ||||
| VC Round | Feb 25, 2020 | ||||
Series B | Dec 15, 2015 |
KAHR Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series B |
| Korea Investment Partners | Series B |
| Mirae Asset | VC Round, Series D Extension |
| Israel Innovation Authority | Seed |
| Flerie Invest | VC Round |
| The University of Texas MD Anderson Cancer Center | VC Round |
| Consensus Business Group | Series D Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Raised $22M led by amoon-fund, Cancer Focus Fund, Peregrine Ventures, Flerie, and Flerie AB.
- Oct 14, 2025
$22M round completed.
KAHR Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KAHR Medical's valuation, stock price, and market status.